Skip to main content

Table 1 Clinical parameters of Kawasaki disease patients

From: Activin a suppresses peripheral CD8+ T lymphocyte activity in acute-phase Kawasaki disease

Sex KD1 KD2 KD3 KD4 KD5 KD6 KD7
Male Male Male Male Female Female Female
Age(y) 3.92 1.25 1.75 2.17 1.17 1.50 1.75
WBC(109/L) 22.67 9.18 12.31 21.78 28.34 20.54 17.76
RBC(1012/L) 4.19 4.56 4.24 3.91 3.96 4.03 3.94
Hemoglobin(g/L) 116 116 114 109 105 104 97
PLT (109/L) 535 370 565 602 527 457 454
CRP (mg/L) 67.7 99.8 12.56 174.97 78.7 35.4 37
TBil (umol/L) 5.8 12.5 4.2 10.2 4.7 7.9 4.2
ALT (IU/L) 529 27 12 32 68 14 21
AST (IU/L) 131 31 19 21 35 20 23
Sodium (mmol/L) 134.2 126.7 138.9 130 135.6 138.8 136.9
ESR (mm/h) 63 32 46 58 87 90 89
PCT (ng/ml) 1.75 1.95 0.16 1.26 7.38 0.33 0.16
  1. KD Kawasaki disease, y Year, WBC White blood cell counts, RBC Red blood cell counts, PLT Platelet, CRP C-reactive protein, TBil Total bilirubin, ALT Alanine aminotransferase, AST Aspartate aminotransferase, ESR Erythrocyte sedimentation rate, PCT Procalcitonin